International Conference on Hematology and Clinical Research
(ICHACR-26)

24th October 2026 || Lucknow - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Hematology and Clinical Research (ICHACR), scheduled to be held on 24th October 2026 in Lucknow, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Hematology.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Molecular Diagnostics
    This track will explore the latest innovations in molecular diagnostics within hematology, focusing on their impact on disease detection and management. Participants will discuss the integration of these technologies into clinical practice and their implications for patient outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Innovative Therapeutic Strategies in Hematology
    This session will highlight cutting-edge therapeutic approaches for hematological disorders, including novel drug developments and treatment protocols. Experts will share insights on the efficacy and safety of these strategies in clinical settings. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 03 – Biomarker Identification and Application
    This track will delve into the identification and validation of biomarkers relevant to hematological diseases. Discussions will focus on their role in diagnosis, prognosis, and treatment response. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Clinical Trials in Hematology
    This session will provide an overview of ongoing and completed clinical trials in the field of hematology. Researchers will present findings and discuss the implications of trial results for future therapeutic developments. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 05 – Translational Research in Hematology
    This track will emphasize the importance of translational research in bridging laboratory discoveries with clinical applications in hematology. Participants will examine case studies that illustrate successful translation of research findings into patient care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 06 – Disease Mechanisms in Hematological Disorders
    This session will investigate the underlying mechanisms of various hematological diseases, including genetic, environmental, and immunological factors. Experts will discuss how these mechanisms inform treatment strategies and patient management. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 07 – Patient Care and Quality of Life
    This track will focus on the holistic aspects of patient care in hematology, emphasizing the importance of quality of life for patients. Discussions will include supportive care strategies and the psychosocial impact of hematological diseases. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 08 – Laboratory Techniques in Hematology
    This session will cover advanced laboratory techniques used in the diagnosis and monitoring of hematological conditions. Participants will share best practices and innovations that enhance laboratory efficiency and accuracy. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 09 – Emerging Trends in Hematology Research
    This track will highlight emerging trends and future directions in hematology research, including novel technologies and interdisciplinary approaches. Researchers will discuss how these trends may shape the future of clinical practice. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Ethical Considerations in Hematology Research
    This session will address the ethical challenges and considerations inherent in hematology research and clinical trials. Experts will engage in discussions about informed consent, patient safety, and the responsible conduct of research. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 11 – Global Perspectives on Hematology
    This track will provide a platform for discussing global health issues related to hematology, including disparities in access to care and treatment. Participants will share insights on how to improve hematological care in diverse populations. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure
  • SDG 10 SDG 10
    Reduced Inequalities

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228